KaterynaFedorovMD

Physician

Dr. Fedorov is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2017 - 2020
State University of New York Downstate Medical Center College of MedicineClass of 2017

PubMed

Complete remission in a case of acute undifferentiated leukemia with novel combination therapy of FLAG-IDA and venetoclax.
Roma A Kankaria, Jeremy B Jones, Michael Zargari, Dylan Wrinn Alexander, Hannah Angle
Leukemia & Lymphoma. 2024-10-16
Case report: Isolated oligometastatic disease of the prostate from a primary lung adenocarcinoma.
Josette M Kamel, Simran Arjani, Kateryna Fedorov, Fnu Sapna, Jinrong Cheng
Frontiers in Oncology. 2024-01-01
5 citations
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML.
David Levitz, Yogen Saunthararajah, Kateryna Fedorov, Lauren C Shapiro, Ioannis Mantzaris
Clinical Cancer Research. 2023-08-01

Abstracts/Posters

Neutrophil Extracellular Traps (NETs) Are a Subset of Smudge Cells Identifiable By Peripheral Smear Autoanalyzers
Kateryna Fedorov, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Direct Oral Anticoagulants for Prevention of Recurrent Thrombosis in Myeloproliferative Neoplasms
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019